NPCE
Ticker
NeuroPace Inc
Company
Devices
Industry
Healthcare
Sector
Financial Ratio Analysis
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”11.3%9.8%0.7%43.7%22.1%β€”24.1%
Revenue Growth QoQ
β€”11.3%9.8%0.7%43.7%22.1%β€”β€”
Gross Margin
71.6%73.6%74.0%71.4%73.6%73.9%β€”76.8%
EBITDA Margin
-58.4%-31.0%-51.9%-89.0%-41.3%-26.9%β€”-19.0%
Operating Margin
-59.6%-31.7%-52.5%-89.6%-41.5%-27.1%β€”-19.2%
Profit Margin
-81.1%-59.0%-79.9%-103.4%-50.4%-34.0%β€”-25.3%
FCF / EBITDA
118.0%170.1%106.5%92.5%73.6%85.0%β€”92.0%